The global CRISPR Gene Editing Service market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global CRISPR Gene Editing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CRISPR Gene Editing Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global CRISPR Gene Editing Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global CRISPR Gene Editing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global CRISPR Gene Editing Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRISPR Gene Editing Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRISPR Gene Editing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AMSBIO, GenScript, Merck, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, DefiniGEN, Synthego, Biocytogen, Caribou, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
CRISPR Gene Editing Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
CRISPR-Cas9
CRISPR-Cas12a (Cpf1)
Other
麻豆原创 segment by Application
Cell Line Construction
Animal Models
Bioagriculture
Other
麻豆原创 segment by players, this report covers
AMSBIO
GenScript
Merck
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
DefiniGEN
Synthego
Biocytogen
Caribou
Horizo鈥嬧�媙 Discovery Ltd.
EdiGene, Inc.
DetaiBio
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRISPR Gene Editing Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR Gene Editing Service, with revenue, gross margin, and global market share of CRISPR Gene Editing Service from 2020 to 2025.
Chapter 3, the CRISPR Gene Editing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and CRISPR Gene Editing Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR Gene Editing Service.
Chapter 13, to describe CRISPR Gene Editing Service research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of CRISPR Gene Editing Service by Type
1.3.1 Overview: Global CRISPR Gene Editing Service 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global CRISPR Gene Editing Service Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 CRISPR-Cas9
1.3.4 CRISPR-Cas12a (Cpf1)
1.3.5 Other
1.4 Global CRISPR Gene Editing Service 麻豆原创 by Application
1.4.1 Overview: Global CRISPR Gene Editing Service 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Cell Line Construction
1.4.3 Animal Models
1.4.4 Bioagriculture
1.4.5 Other
1.5 Global CRISPR Gene Editing Service 麻豆原创 Size & Forecast
1.6 Global CRISPR Gene Editing Service 麻豆原创 Size and Forecast by Region
1.6.1 Global CRISPR Gene Editing Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global CRISPR Gene Editing Service 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America CRISPR Gene Editing Service 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe CRISPR Gene Editing Service 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific CRISPR Gene Editing Service 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America CRISPR Gene Editing Service 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa CRISPR Gene Editing Service 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 AMSBIO
2.1.1 AMSBIO Details
2.1.2 AMSBIO Major Business
2.1.3 AMSBIO CRISPR Gene Editing Service Product and Solutions
2.1.4 AMSBIO CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 AMSBIO Recent Developments and Future Plans
2.2 GenScript
2.2.1 GenScript Details
2.2.2 GenScript Major Business
2.2.3 GenScript CRISPR Gene Editing Service Product and Solutions
2.2.4 GenScript CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 GenScript Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck CRISPR Gene Editing Service Product and Solutions
2.3.4 Merck CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Merck Recent Developments and Future Plans
2.4 Editas Medicine
2.4.1 Editas Medicine Details
2.4.2 Editas Medicine Major Business
2.4.3 Editas Medicine CRISPR Gene Editing Service Product and Solutions
2.4.4 Editas Medicine CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Editas Medicine Recent Developments and Future Plans
2.5 Intellia Therapeutics
2.5.1 Intellia Therapeutics Details
2.5.2 Intellia Therapeutics Major Business
2.5.3 Intellia Therapeutics CRISPR Gene Editing Service Product and Solutions
2.5.4 Intellia Therapeutics CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Intellia Therapeutics Recent Developments and Future Plans
2.6 CRISPR Therapeutics
2.6.1 CRISPR Therapeutics Details
2.6.2 CRISPR Therapeutics Major Business
2.6.3 CRISPR Therapeutics CRISPR Gene Editing Service Product and Solutions
2.6.4 CRISPR Therapeutics CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 CRISPR Therapeutics Recent Developments and Future Plans
2.7 DefiniGEN
2.7.1 DefiniGEN Details
2.7.2 DefiniGEN Major Business
2.7.3 DefiniGEN CRISPR Gene Editing Service Product and Solutions
2.7.4 DefiniGEN CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 DefiniGEN Recent Developments and Future Plans
2.8 Synthego
2.8.1 Synthego Details
2.8.2 Synthego Major Business
2.8.3 Synthego CRISPR Gene Editing Service Product and Solutions
2.8.4 Synthego CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Synthego Recent Developments and Future Plans
2.9 Biocytogen
2.9.1 Biocytogen Details
2.9.2 Biocytogen Major Business
2.9.3 Biocytogen CRISPR Gene Editing Service Product and Solutions
2.9.4 Biocytogen CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Biocytogen Recent Developments and Future Plans
2.10 Caribou
2.10.1 Caribou Details
2.10.2 Caribou Major Business
2.10.3 Caribou CRISPR Gene Editing Service Product and Solutions
2.10.4 Caribou CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Caribou Recent Developments and Future Plans
2.11 Horizo鈥嬧�媙 Discovery Ltd.
2.11.1 Horizo鈥嬧�媙 Discovery Ltd. Details
2.11.2 Horizo鈥嬧�媙 Discovery Ltd. Major Business
2.11.3 Horizo鈥嬧�媙 Discovery Ltd. CRISPR Gene Editing Service Product and Solutions
2.11.4 Horizo鈥嬧�媙 Discovery Ltd. CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Horizo鈥嬧�媙 Discovery Ltd. Recent Developments and Future Plans
2.12 EdiGene, Inc.
2.12.1 EdiGene, Inc. Details
2.12.2 EdiGene, Inc. Major Business
2.12.3 EdiGene, Inc. CRISPR Gene Editing Service Product and Solutions
2.12.4 EdiGene, Inc. CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 EdiGene, Inc. Recent Developments and Future Plans
2.13 DetaiBio
2.13.1 DetaiBio Details
2.13.2 DetaiBio Major Business
2.13.3 DetaiBio CRISPR Gene Editing Service Product and Solutions
2.13.4 DetaiBio CRISPR Gene Editing Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 DetaiBio Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global CRISPR Gene Editing Service Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of CRISPR Gene Editing Service by Company Revenue
3.2.2 Top 3 CRISPR Gene Editing Service Players 麻豆原创 Share in 2024
3.2.3 Top 6 CRISPR Gene Editing Service Players 麻豆原创 Share in 2024
3.3 CRISPR Gene Editing Service 麻豆原创: Overall Company Footprint Analysis
3.3.1 CRISPR Gene Editing Service 麻豆原创: Region Footprint
3.3.2 CRISPR Gene Editing Service 麻豆原创: Company Product Type Footprint
3.3.3 CRISPR Gene Editing Service 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global CRISPR Gene Editing Service Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global CRISPR Gene Editing Service 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global CRISPR Gene Editing Service Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global CRISPR Gene Editing Service 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America CRISPR Gene Editing Service Consumption Value by Type (2020-2031)
6.2 North America CRISPR Gene Editing Service 麻豆原创 Size by Application (2020-2031)
6.3 North America CRISPR Gene Editing Service 麻豆原创 Size by Country
6.3.1 North America CRISPR Gene Editing Service Consumption Value by Country (2020-2031)
6.3.2 United States CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe CRISPR Gene Editing Service Consumption Value by Type (2020-2031)
7.2 Europe CRISPR Gene Editing Service Consumption Value by Application (2020-2031)
7.3 Europe CRISPR Gene Editing Service 麻豆原创 Size by Country
7.3.1 Europe CRISPR Gene Editing Service Consumption Value by Country (2020-2031)
7.3.2 Germany CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Gene Editing Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific CRISPR Gene Editing Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific CRISPR Gene Editing Service 麻豆原创 Size by Region
8.3.1 Asia-Pacific CRISPR Gene Editing Service Consumption Value by Region (2020-2031)
8.3.2 China CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America CRISPR Gene Editing Service Consumption Value by Type (2020-2031)
9.2 South America CRISPR Gene Editing Service Consumption Value by Application (2020-2031)
9.3 South America CRISPR Gene Editing Service 麻豆原创 Size by Country
9.3.1 South America CRISPR Gene Editing Service Consumption Value by Country (2020-2031)
9.3.2 Brazil CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Gene Editing Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa CRISPR Gene Editing Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa CRISPR Gene Editing Service 麻豆原创 Size by Country
10.3.1 Middle East & Africa CRISPR Gene Editing Service Consumption Value by Country (2020-2031)
10.3.2 Turkey CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE CRISPR Gene Editing Service 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 CRISPR Gene Editing Service 麻豆原创 Drivers
11.2 CRISPR Gene Editing Service 麻豆原创 Restraints
11.3 CRISPR Gene Editing Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 CRISPR Gene Editing Service Industry Chain
12.2 CRISPR Gene Editing Service Upstream Analysis
12.3 CRISPR Gene Editing Service Midstream Analysis
12.4 CRISPR Gene Editing Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
AMSBIO
GenScript
Merck
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
DefiniGEN
Synthego
Biocytogen
Caribou
Horizo鈥嬧�媙 Discovery Ltd.
EdiGene, Inc.
DetaiBio
听
听
*If Applicable.